Notice: Prescription Drug List (PDL): Polymyxin B

April 22, 2016
Our file number: 16-104360-380

The purpose of this Notice of Amendment is to notify that Health Canada will switch certain uses of Polymyxin B to prescription status for veterinary use by adding it to the Veterinary Prescription Drug List (PDL). The Human listing for Polymyxin B of the PDL remains unchanged. Health Canada has conducted a scientific review of Polymyxin B against a set of established and publicly available criteria outlined in section C.01.040.3 of the Food and Drug Regulations. The listing now reads:

Drugs containing the following: Polymyxin B or its salts or derivatives

Qualifier: when sold in combination with other medicinal ingredients

Effective Date: date of this Notice

Should you have any questions on this update to the Prescription Drug List, please contact:

Prescription Drug Status Committee
Health Canada
Holland Cross, Tower B, 2nd Floor
1600 Scott Street
Address Locator 3102C3
Ottawa, Ontario
K1A 0K9

Email: drug_prescription_status-statut_d'
Phone: 613-957-1058
Fax: 613-941-1812

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: